1.
International Journal of Infectious Diseases
; 94:41-43, 2020.
Article
in English
| CAB Abstracts | ID: covidwho-1409649
ABSTRACT
Failure of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine may occur despite perfect adherence, although this is uncommon. Failure results in breakthrough HIV infection. Delayed seroconversion associated with antiretroviral use may complicate the picture, causing uncertainties in interpreting adherence patterns for establishing the true cause of PrEP failure.